Methods for amplifying Hepatitis C virus nucleic acids

Details for Australian Patent Application No. 2010210892 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kwong, Ann D.; Frantz, James Daniel; Bartels, Douglas J.; Lin, Chao; Shames, Benjamin; Seepersaud, Sheila; Lippke, Judith A.; Kieffer, Tara L.; Zhou, Yi; Zhang, Eileen Z.; Sullivan, James C.

Agent Baldwins

Pub. Number AU-A-2010210892

PCT Pub. Number WO2010/090857

Priority 61/146,083 21.01.09 US

Filing date 21 January 2010

Wipo publication date 12 August 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/090857 Priority application(s): WO2010/090857

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210894-Methods of diagnosing and treating multiple sclerosis

2010210890-Oral care composition to reduce or eliminate dental sensitivity